Japanese phase1 Study of Belimumab (IV vs SC)
NCT01516450
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
DRUG:
GSK1550188 IV
DRUG:
GSK1550188 SC
Sponsor
GlaxoSmithKline